Rhythm Biosciences Limited (ASX:RHY)
Australia · Delayed Price · Currency is AUD 0.0930
-0.0050 (-5.10%)
Oct 31, 2025, 12:02 PM AEST
Rhythm Biosciences Company Description
Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States.
It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development.
The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Rhythm Biosciences Limited
| Country | Australia |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| CEO | David Atkins |
Contact Details
Address: Bio21 Institute Parkville, 3010 Australia | |
| Phone | 61 3 8256 2880 |
| Website | rhythmbio.com |
Stock Details
| Ticker Symbol | RHY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU000000RHY2 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Dr. David Atkins M.B.A., Ph.D. | Chief Executive Officer and Director |
| Otto Leslie-Steven Buttula AIMM, B.Ec., Grad. Dip., MAICD | Executive Chairman |
| Todd Perkinson | Chief Financial Officer |